Robert Morris
Robert Morris is the editor of Penny Stock All-Stars, an investment advisory focused on discovering small-cap and micro-cap stocks that are destined to become the market’s next Blue Chips.
The Wall Street veteran and small-cap stock specialist is also a regular contributor to Penny Stock Research. Every week, Robert shares his thoughts with our readers on a variety of penny stock-related topics.
In addition to Penny Stock Research, Robert also writes frequently for two other free financial e-letters, ETF Trading Research and the Dynamic Wealth Report. He’s also the editor of two highly successful and popular investment advisories, Biotech SuperTrader and China Stock Insider.
Robert Morris's Latest Posts
Ignore The Naysayers… Buy Chinese Stocks!
China’s making headlines again. And once again, it’s for all the wrong reasons. On Friday, China’s National Bureau of Statistics reported that industrial production rose just 9.3% year over year in April. That’s down from 11.9% growth in March. And the number missed estimates for an increase of 12.2%. The disappointing industrial production data follows […]
Three Reasons Why I’m Not Buying The Facebook IPO
The month of May 2012 is set to go down in history. It will forever be remembered as the month Facebook finally went public. That’s right. After months of speculation, the most highly anticipated IPO of all time is nearly ready to go. And if it all comes off as planned, it will be the […]
Biotech Stocks: Time To Pounce On These Biotech Takeover Targets?
Back in February, I wrote about the recent biotech buyout binge in my article, Takeover Mania Sweeping Biotech Sector. A number of lucrative takeovers in the biotech industry had sparked a stunning rally in biotech stocks. Investors were snapping up biotech shares faster than NBA player, Metta World Peace picks up game suspensions. Each one […]
China GDP: Slower Chinese GDP Growth Bodes Well For Global Economy
The news media is all atwitter over China’s first quarter GDP number. No matter where you look, some pundit claims China’s first quarter GDP growth spells doom for China and the global economy. It’s shock journalism of the most shameless variety. At first blush, the news certainly looks grim. The world’s fastest growing major economy […]
Supercharge Your Portfolio With Penny Stocks
When was the last time you made ten times your money on a single stock trade? Heck, can you remember the last time you quadrupled or even tripled your money on a stock? Most ordinary investors will have a hard time coming up with an answer to these simple questions. That’s because most people invest […]
Internet Stocks: Groupon Caught Cheating!
Investors who got an early start on their weekend plans missed some big news on Friday afternoon. Internet sensation Groupon (GRPN) announced after the close they’re restating financial results for the fourth quarter and full year 2011. We’ll get to the dirty details in just a moment. But first a quick recap of the company. […]
Goldman’s Bold Prediction…
Last week I warned investors the market is heading for a correction. In my humble opinion, skyrocketing gas prices, slowing corporate earnings growth, and the increasing likelihood of a recession in Europe are making it tough for the early 2012 market rally to sustain itself. And as if right on cue, the market stumbled last […]
US Stock Market Update: Get Ready For A Market Correction
I know it sounds crazy. Saying the market is primed for a fall feels a lot like saying the sun won’t rise tomorrow. But maybe that’s precisely why it’s time to get prepared now for a market correction. The market has been screaming higher since early October. The Dow Jones Industrials have gained over 2,400 […]
Chinese Stocks: Chinese Stocks About To Get A Boost…
The Chinese government shocked global investors last week. Prime Minister Wen Jiabao said China’s growth target for 2012 has been lowered from 8% to 7.5%. It was a huge departure from China’s current policy. You see, the government has had a growth target of 8% annually since 2005. And most experts believe China’s economy must […]
Biotech Stocks: Friendlier FDA Making Biotech Investors Rich!
Betting on biotechs with new drugs coming up for FDA approval may have just become the best game in town. After a stingy 2010 in which only 21 new drugs gained regulatory approval, the FDA essentially opened the flood gates in 2011. Last year, the FDA approved a whopping 35 new medicines. It’s the second […]
